Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults

Journal of Human Hypertension

Volumn 27, Issue 6, 2013, Pages 397-399

  Semba, R D ^a   Crasto, C ^a   Strait, J ^b   Sun, K ^a   Schaumberg, D A ^c   Ferrucci, L ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMMUNITY LIVING; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RACE; SELF REPORT; SMOKING; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS;

EID: 84877597282     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2012.52     Document Type: Letter

References (12)

1. Kliewer SA, Mangelsdorf DJ. Fibroblast growth factor 21: from pharmacology to physiology. Am J Clin Nutr 2010; 91(Suppl): 254S-257S.
2. Kharitonenkov A, Larsen P. FGF21 reloaded: challenges of a rapidly growing field. Trends Endocrinol Metab 2011; 22: 81-86.
3. Zhang X, Yeung DCY, Karpisek M, Stejskal D, Zhou ZG, Liu F et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008; 57: 1246-1253.
4. Lin Z, Wu Z, Yin X, Liu Y, Yan X, Lin S et al. Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile. PLoS One 2010; 5: e15534.
5. Semba RD, Sun K, Egan JM, Crasto C, Carlson OD, Ferrucci L. Elevated serum fibroblast growth factor 21 is associated with abnormal glucose metabolism and insulin resistance: the Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2012; 97(4): 1375-1382.
6. An SY, Lee MS, Yi SA, Ha ES, Han SJ, Kim HJ et al. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques. Diabetes Res Clin Pract 2012; 96(2): 196-203.
7. Coffman TM. Under pressure: the search for the essential mechanisms of hypertension. Nat Med 2011; 17: 1402-1409.
8. Yang SJ, Hong HC, Choi HY, Yoo HJ, Cho GJ, Hwang TG et al. Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women. Clin Endocrinol 2011; 75: 464-469.
9. Franklin SS. Arterial stiffness and hypertensions: a two-way street? Hypertension 2005; 45: 349-351.
10. Shock NW, Greulich RC, Andres RA, Arenberg D, Costa Jr PT, Lakatta EG et al. Normal Human Aging: the Baltimore Longitudinal Study of Aging. US Government Printing Office: Washington, DC, 1984.
11. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Doato KA et al. Harmonizing the metabolic syndrome: a joint interim statement from the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
12. Han SH, Choi SH, Cho BJ, Lee Y, Lim S, Park YJ et al. Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis. Metabolism 2010; 59: 1565-1662.